Showing results (51-60 of 312) with videos related to
Sort By:
Pageof 32
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysisC Bokemeyer, C Kollmannsberger, C Meisner, et al.Anticancer Research|March 28, 2001
Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamideJ T Hartmann, L M Fels, A Franzke, et al.World Journal of Urology|June 29, 2004
Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experienceM A Kuczyk, C Bokemeyer, C Kollmannsberger, et al.Onkologie|January 13, 2004
[Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients]C Bokemeyer, F HoneckerHamostaseologie|July 28, 2011
Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factorF Langer, C BokemeyerBritish Journal of Cancer|July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialR-D Hofheinz, J T Hartmann, A Willer, et al.British Journal of Cancer|December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation studyJ T Hartmann, K Oechsle, D Quietzsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, S Weinknecht, et al.Pageof 32